Clinical Trials Update: Aug. 29, 2006
Crohn's Disease Psoriasis and Psoriatic Disorders Post-Menopausal Osteoporosis
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study will evaluate Humira, an investigational human antibody, in people with Crohn's disease. Volunteers 18-75 who have moderate-to-severe active Crohn's, have stopped taking Remicade, and have not been treated with Humira (adalimumab) previously may qualify.
The research site is in Beachwood, Ohio.
Psoriasis and Psoriatic Disorders
This study for people with mild-to-moderate psoriasis will evaluate treating the condition with pritopic cream. Otherwise healthy volunteers with mild-to-moderate psoriasis and who are not pregnant may be eligible.
The research site is in Seattle, Wash.
This is a research study for women at risk of osteoporosis. Healthy post-menopausal women between 50 and 85 with below-normal bone density who have had a bone fracture or have family history of osteoporosis may be included. Two overnight stays are required and candidates may be compensated up to $800 for time and travel.
The research site is in Bingham Farms, Mich.
Copyright 2006 Thomson CenterWatch. All rights reserved.